BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11790979)

  • 21. Carcinoid syndroma - diagnosis and management.
    Kiňová S; Koreň M
    Vnitr Lek; 2021; 67(5):310-314. PubMed ID: 35459398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumors.
    Welin S; Stridsberg M; Cunningham J; Granberg D; Skogseid B; Oberg K; Eriksson B; Janson ET
    Neuroendocrinology; 2009; 89(3):302-7. PubMed ID: 19176944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of midgut carcinoids.
    Akerström G; Hellman P; Hessman O; Osmak L
    J Surg Oncol; 2005 Mar; 89(3):161-9. PubMed ID: 15719373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center.
    Janson ET; Holmberg L; Stridsberg M; Eriksson B; Theodorsson E; Wilander E; Oberg K
    Ann Oncol; 1997 Jul; 8(7):685-90. PubMed ID: 9296223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids.
    Kytölä S; Höög A; Nord B; Cedermark B; Frisk T; Larsson C; Kjellman M
    Am J Pathol; 2001 May; 158(5):1803-8. PubMed ID: 11337378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in gastrointestinal carcinoids.
    Krishnamurthy S; Dayal Y
    Am J Surg Pathol; 1997 Mar; 21(3):327-33. PubMed ID: 9060603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors.
    Ilias I; Pacak K
    Nucl Med Biol; 2008 Aug; 35 Suppl 1(Suppl 1):S27-34. PubMed ID: 18707631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinoid tumors of the extrahepatic bile ducts: a study of seven cases.
    Maitra A; Krueger JE; Tascilar M; Offerhaus GJ; Angeles-Angeles A; Klimstra DS; Hruban RH; Albores-Saavedra J
    Am J Surg Pathol; 2000 Nov; 24(11):1501-10. PubMed ID: 11075851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin and carcinoid tumors.
    Ahlman H
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S79-85. PubMed ID: 2412066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State of the art and future prospects in the management of neuroendocrine tumors.
    Oberg K
    Q J Nucl Med; 2000 Mar; 44(1):3-12. PubMed ID: 10932597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient symptomatic control of carcinoid tumors with somatostatin in patients with disease progression under alpha-interferon therapy.
    Boehme MW; Schmidt-Gayk H; Bihl H; Eisenhut M; Herfarth CH; Kommere B; Raeth U
    Hepatogastroenterology; 1995; 42(6):1053-61. PubMed ID: 8847018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development and characterization of a human midgut carcinoid cell line.
    Van Buren G; Rashid A; Yang AD; Abdalla EK; Gray MJ; Liu W; Somcio R; Fan F; Camp ER; Yao JC; Ellis LM
    Clin Cancer Res; 2007 Aug; 13(16):4704-12. PubMed ID: 17699847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison between the efficacy of somatostatin receptor scintigraphy and that of in situ hybridization for somatostatin receptor subtype 2 messenger RNA to predict therapeutic outcome in carcinoid patients.
    Janson ET; Gobl A; Kälkner KM; Oberg K
    Cancer Res; 1996 Jun; 56(11):2561-5. PubMed ID: 8653698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoamine and diamine oxidase activity in the diagnosis of carcinoid tumors.
    Feldman JM
    Cancer; 1985 Dec; 56(12):2855-60. PubMed ID: 3931898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroendocrine tumors of the diffuse neuroendocrine system.
    Gustafsson BI; Kidd M; Modlin IM
    Curr Opin Oncol; 2008 Jan; 20(1):1-12. PubMed ID: 18043250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two different types of carcinoid tumors of the lung: immunohistochemical and ultrastructural investigation and their histogenetic consideration.
    Min KW
    Ultrastruct Pathol; 2013 Feb; 37(1):23-35. PubMed ID: 23383615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinoids of unknown origin: comparative analysis with foregut, midgut, and hindgut carcinoids.
    Kirshbom PM; Kherani AR; Onaitis MW; Feldman JM; Tyler DS
    Surgery; 1998 Dec; 124(6):1063-70. PubMed ID: 9854584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids.
    Granberg D; Wilander E; Stridsberg M; Granerus G; Skogseid B; Oberg K
    Gut; 1998 Aug; 43(2):223-8. PubMed ID: 10189848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug therapy of carcinoids of the gastrointestinal tract].
    Engelbach M; Heusel CP; Kriegsmann J; Both S; Walgenbach S
    Zentralbl Chir; 2001 Sep; 126(9):682-5. PubMed ID: 11699283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome).
    de Herder WW
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):705-15. PubMed ID: 16253895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.